Newman M J, Wu J Y, Gardner B H, Munroe K J, Leombruno D, Recchia J, Kensil C R, Coughlin R T
Cambridge Biotech Corporation, Worcester, MA 01605.
J Immunol. 1992 Apr 15;148(8):2357-62.
The ability of a saponin adjuvant, QS-21, to induce OVA-specific, class I MHC Ag-restricted CTL was investigated using different forms of soluble OVA and OVA adsorbed onto alum as immunogens. C57BL/6 mice were immunized with soluble native or denatured OVA in formulations that contained increasing quantities of QS-21, and CTL responses were measured using EL4 and E.G7-OVA cells as targets and splenic mononuclear cells as effectors. Ag-specific CTL responses were produced but only if the QS-21 adjuvant was used. Similar responses were induced using alum-adsorbed OVA when mixed with the QS-21 adjuvant but not when used alone. The CTL were specific for an epitope present on the OVA258-276 synthetic peptide, which contains the dominant CTL epitope recognized by C57BL/6 mice. The CD8+ subpopulation of lymphocytes in immune mice was not increased in spleens but increased significantly in vitro after culture with soluble OVA. The CTL activity of splenic mononuclear cell preparations was totally destroyed by treatment with mAb specific to the CD8 Ag plus complement. The ability of the QS-21 adjuvant to induce class I MHC Ag-restricted CTL after immunization with soluble proteins is a characteristic unique to saponin adjuvants.
使用不同形式的可溶性卵清蛋白(OVA)和吸附在明矾上的OVA作为免疫原,研究了皂苷佐剂QS-21诱导OVA特异性、I类主要组织相容性复合体(MHC)抗原限制性细胞毒性T淋巴细胞(CTL)的能力。用含有递增剂量QS-21的制剂对C57BL/6小鼠进行可溶性天然或变性OVA免疫,并以EL4和E.G7-OVA细胞作为靶细胞、脾单核细胞作为效应细胞来检测CTL反应。仅当使用QS-21佐剂时才产生抗原特异性CTL反应。当与QS-21佐剂混合使用时,用明矾吸附的OVA可诱导类似反应,但单独使用时则不能。这些CTL对OVA258-276合成肽上存在的一个表位具有特异性,该合成肽包含C57BL/6小鼠识别的主要CTL表位。免疫小鼠脾脏中淋巴细胞的CD8+亚群没有增加,但在与可溶性OVA培养后体外显著增加。用针对CD8抗原的单克隆抗体加补体处理后,脾单核细胞制剂的CTL活性完全被破坏。用可溶性蛋白免疫后,QS-21佐剂诱导I类MHC抗原限制性CTL的能力是皂苷佐剂独有的特征。